Literature DB >> 1535658

Surgery and medical treatment in persistent somatizing patients.

P Fink1.   

Abstract

This study describes the utilization of surgical operations, frequency and outcome of medical and surgical treatment in a group of persistent somatizers compared with a control group of non-somatizers. The study was carried out using the Danish national medical register to identify persons in the general population (age range 17-49 yr) with at least 10 general admissions during an 8-yr period. Persistent somatizers were defined as persons with more than six medically unexplained general hospital admissions in their lifetimes before 1985. Conversely, non-somatizers were patients whose admissions could mainly be ascribed to well-defined somatic disorders. The findings show that persistent somatizers had been exposed to extensive surgery, outnumbering the non-somatizers. Surgical operations were of several categories, with gastrointestinal and gynaecological operations being the most frequent. The physicians used medical and surgical treatment nearly as often for treating persistent somatizers as in the treatment of the non-somatizers. Surgical or medical treatment was used in nearly half of the medically unexplained admissions. The outcome of the surgical treatment of the persistent somatizers was, however, generally unsuccessful in that the effect was unsatisfactory in three quarters of cases. Similarly, two thirds of the medical treatments were judged to be unsuccessful in persistent somatizers. The findings suggest that the costs of somatic diagnostic procedures and fruitless surgical and medical treatment attempts on persistent somatizers are enormous, and only exceeded by the risk of iatrogenic harm. This emphasizes the need for an early diagnosis of somatization and of treating it properly.

Entities:  

Mesh:

Year:  1992        PMID: 1535658     DOI: 10.1016/0022-3999(92)90004-l

Source DB:  PubMed          Journal:  J Psychosom Res        ISSN: 0022-3999            Impact factor:   3.006


  33 in total

1.  The cost of somatisation among the working-age population in England for the year 2008-2009.

Authors:  Sarah L Bermingham; Alan Cohen; John Hague; Michael Parsonage
Journal:  Ment Health Fam Med       Date:  2010-06

2.  Should purchasers pay for psychotherapy?

Authors:  T Fahy; S Wessely
Journal:  BMJ       Date:  1993-09-04

3.  The use of PRIME-MD questionnaire in a rheumatology clinic.

Authors:  A S Russell; B K Hui
Journal:  Rheumatol Int       Date:  2004-12-10       Impact factor: 2.631

4.  The Othmer and DeSouza test for screening of somatisation disorder: is it useful in general practice?

Authors:  P Zaballa; Y Crega; G Grandes; C Peralta
Journal:  Br J Gen Pract       Date:  2001-03       Impact factor: 5.386

Review 5.  Symptom evaluation in reflux disease: workshop background, processes, terminology, recommendations, and discussion outputs.

Authors:  J Dent; D Armstrong; B Delaney; P Moayyedi; N J Talley; N Vakil
Journal:  Gut       Date:  2004-05       Impact factor: 23.059

6.  Diagnostic accuracy of predicting somatization from patients' ICD-9 diagnoses.

Authors:  Robert C Smith; Joseph C Gardiner; Zhehui Luo; Kathryn Rost
Journal:  Psychosom Med       Date:  2009-03-17       Impact factor: 4.312

Review 7.  [Concepts of in-patient gradual diagnostics for patients with lumbar back-pain].

Authors:  R Kayser; K Mahlfeld; C E Heyde
Journal:  Orthopade       Date:  2008-04       Impact factor: 1.087

8.  Prevalence of somatoform pain complaints in the German population.

Authors:  Aike Hessel; Manfred Beutel; Michael Geyer; Jörg Schumacher; Elmar Brähler
Journal:  Psychosoc Med       Date:  2005-03-21

Review 9.  [Patients with pre-existing chronic pain and/or psychological problems].

Authors:  M Schiltenwolf; R Klinger
Journal:  Orthopade       Date:  2008-10       Impact factor: 1.087

10.  In their own words: qualitative study of high-utilising primary care patients with medically unexplained symptoms.

Authors:  Francesca C Dwamena; Judith S Lyles; Richard M Frankel; Robert C Smith
Journal:  BMC Fam Pract       Date:  2009-09-21       Impact factor: 2.497

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.